Visalytics
Visalytics
approved EB-2 (NIW)

Associate Research Scientist

Biostatistics · China · 2022-04-05

Processing Time
367 days
Decision Date
2022-04-05
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop and apply novel statistical methodologies to more accurately evaluate healthcare data and improve treatment efficacy. Her work focuses on characterizing the mechanisms for conditions such as cancer and COVID-19 to improve global treatment strategies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses prevalent and deadly diseases like cancer and COVID-19, which are of clear national importance to U.S. medical interests.

2 Well-positioned to Advance the Endeavor Met

The petitioner is uniquely well-positioned due to her leadership, expertise, and record of 27 publications and 131 citations.

3 Balance of Factors Met

The petitioner's work is crucial for addressing gaps in medical knowledge, making it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 27 peer-reviewed journal articles and 131 citations, demonstrating significant impact. Additionally, she completed 22 peer reviews for scientific journals and provided 4 expert recommendation letters, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions

Similar Cases

Research Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
Massachusetts 151 days 2025-02-27
The petitioner proposes to refine statistical methodologies for experimental and observational studies to improve the quality of clinical data interpretation. Her work focuses on enhancing the reliability of healthcare research across various disease contexts, specifically ensuring that real-world evidence from large-scale datasets is evaluated with scientific rigor.
View Case

Statistician

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
New Jersey 50 days 2025-03-09
The petitioner proposes to enhance the design and analysis of clinical trials through advanced statistical methodologies and machine learning. His work focuses on creating innovative tools that optimize clinical trial accuracy and accelerate therapeutic approvals for oncology, cardiovascular diseases, and infectious diseases. This endeavor aims to improve public health outcomes by ensuring regulatory compliance and addressing safety evaluation challenges in complex medical conditions.
View Case

Statistician

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Georgia 8 days 2023-07-18
The petitioner proposes to advance statistical models for drug development and clinical trial methodologies to improve cancer prognosis and treatment outcomes. His work focuses on time-to-event data analysis to enhance the accurate prediction of patient outcomes, risk stratification, and the optimization of clinical trial designs within the pharmaceutical industry.
View Case

Others

Research and Development · China

WeGreened EB-2 (NIW) approved
California 94 days 2025-02-11
The petitioner proposes to conduct data analysis and medical research on disease development to improve diagnosis and treatment outcomes. Her work focuses on advancing data processing techniques, advanced modeling, simulation, and machine learning to provide actionable insights for a range of diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-05.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 367 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist